Research Row: Approved or on the Horizon Join us as we discuss Approved Therapies and those on the Horizon of approval. Santhera Pharmaceuticals (Vamorolone) Italfarmaco ( Givinostat) PTC Pharmaceuticals (Ataluren, Emflaza) Sarepta Therapeutics (Amondys45, Exondys 51, Vyondys53) NS Pharma (Viltepso) 2023 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 17:20 Pfizer Inc. 5 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 21:45 Audentes Therapeutics 5 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 19:10 Solid Biosciences 5 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 13:05 Astellas Pharma 5 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 12:31 Santhera Pharmaceuticals 5 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 10:23 Cumberland Pharmaceuticals 5 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 7:11 Epirium Bio 5 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin «1…2122232425…28»Page 23 of 28